AXL–GAS6 expression can predict for adverse prognosis in non-small cell lung cancer with brain metastases

PURPOSE: Patients with non-small cell lung cancer (NSCLC) brain metastases (BM) have poor clinical outcomes. We sought to determine if AXL–GAS6 expression can be used as independent prognostic biomarkers for NSCLC BM. METHODS: We retrospectively studied the medical records of 98 patients diagnosed w...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Xiaoliang, Ma, Wenjuan, Zhou, Qianghua, Yan, Haijuan, Lim, Zuan-Fu, Huang, Mayan, Deng, Chuangzhong, Yu, Xingsu, Su, Huifang, Komo, Satoshi, Yang, Haixia, Zhang, Xinke, Wen, Sijin, Zhang, Zhenfeng, Ma, Patrick C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2017
Materias:
Original Article – Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5599460/
https://www.ncbi.nlm.nih.gov/pubmed/28551766
http://dx.doi.org/10.1007/s00432-017-2408-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5599460/
https://www.ncbi.nlm.nih.gov/pubmed/28551766
http://dx.doi.org/10.1007/s00432-017-2408-4

Ejemplares similares